Medical Daily, Jul 2, 2016 04:40 PM The authors of a new study published in Cancer, Epidemiology Biomarkers & Prevention looked at 34 years of data on nearly 3 million women. And it turns out, women with HPV are at risk for more than cervical cancer. The study’s findings suggest that women with HPV are at long-lasting risk for anogenital cancers too. Lead study author Susanne Krüger Kjær...
Guardian, Saturday 2 July 2016 18.00 AEST Jack was born with both male and female anatomy, with ovarian and testicular tissue, and genitals that could belong to either a boy or a girl. He has one of at least 40 congenital variations, known collectively as disorders of sexual development (DSD), or intersex traits. It was months before Juliet and her husband, Will, were told Jack’s specific...
New York Times, Feb 22, 2016
A vaccine introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus’s prevalence in teenage girls by almost two-thirds, US federal researchers said Monday.
Read more here
The Guardian, Friday 29 January 2016 10.03 AEDT Women with abnormal cells on their cervix owing to certain types of human papillomavirus infection are at higher risk of developing breast cancer later in life, the findings from a new study suggest. An expert in medical genetics with the University of Newcastle, Prof Rodney Scott, said it appeared HPV accounted for a “very small” proportion of...
Human Rights Campaign, September 17, 2015 HRC’s research brief published today underscores a dangerous but largely hidden crisis – the striking physical, mental and sexual health disparities bisexual people face. The Health Disparities Among Bisexual People report, based on the most recent and reliable data available on bisexual health and released in partnership with the Bisexual...
medwireNews 10 August 2015
Oral contraceptive use protects against endometrial cancer, with effects persisting for decades after cessation of use, shows a meta-analysis of individual patient data published in The Lancet Oncology.
Read more here